[ad_1] EJBY, Denmark, Nov. 30, 2023 /PRNewswire/ — Today Scantox, together with its majority owner Impilo, has agreed to acquire the neuropharmacology division of QPS Austria GmbH (“QPS Neuro” or…
Tag: BioSpace
Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook | BioSpace
[ad_1] HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing the next generation of…
Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability | BioSpace
[ad_1] Prioritizing metastatic non-small cell lung cancer launch and focusing research and development activities in areas of greatest anticipated value creation Expected reduction in residual operating expenses of approximately $60…
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights | BioSpace
[ad_1] WALTHAM, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients…
Daewoong Pharmaceutical Reports Third Quarter 2023 Financial Results | BioSpace
[ad_1] SEOUL, South Korea, Nov. 1, 2023 /PRNewswire/ — Daewoong Pharmaceutical (KRX: 069620.KS) is pleased to announce its financial results for the third quarter of 2023. Demonstrating a consistent growth…
Opinion: 7 Ways Leveraging Fractional Executives Can Grow Your Biotech Startup | BioSpace
[ad_1] Pictured: Multiple sets of hands push puzzle pieces together/iStock, Lacheev Biotech funding is not great right now. If you’re trying to grow a startup, it’s essential to find ways…
iNtRON, Executes Evaluation License and Option Agreement for SAL200 | BioSpace
[ad_1] iNtRON Grants Basilea exclusive right for preclinical evaluation with an undisclosed payment Basilea has the option to enter into exclusive License Agreement following the evaluation BOSTON…
A New Hope for Epidermolysis Bullosa (“butterfly children”) Thanks to Novel CRISPR-Cas3 Platform | BioSpace
[ad_1] LUGANO, Switzerland & OSAKA, Japan–(BUSINESS WIRE)– Healiva SA (Healiva) and C4U Corporation (C4U) are pleased to announce that they have entered into a strategic alliance agreement regarding the development…
Ascendis Presents Updated and New TransCon™ IL-2 β⁄γ Monotherapy and Combination Therapy Data Confirming Clinical Activity Across Tumor Types at ESMO 2023 | BioSpace
[ad_1] — Clinical responses with TransCon IL-2 β⁄γ demonstrated as monotherapy or in combination with checkpoint inhibitor, including in two of three small cell lung cancer patients treated with combination therapy — TransCon…
AGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene’s New Cell Therapy Product | BioSpace
[ad_1] SEATTLE–(BUSINESS WIRE)– AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new service agreement with Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime…